Upload Avatar (500 x 500)
Qing Chang
Basic Medical Sciences
Peking University
Beijing
Language: Chinese, English
Molecular Typing
Biomarkers
Mechanism Studies
Exosomes
Mirna
Brain Tumors
Tumor Progression
Macrophages
Astrocytes
Pparγ
Areas of Focus
- Tumor molecular pathology
- Exosomal miRNA in brain tumor development
- Tumor microenvironment in brain tumors
Academic Background & Achievements
- Graduated from the Department of Pathology, Faculty of Medicine, Chinese University of Hong Kong with a PhD degree.
- Visiting Scholar at the University of Washington, USA in 2016.
- Established the first domestic molecular typing platform for medulloblastoma based on Nanostring technology.
- Applied for three national patents.
Publications
- Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma, Qing Chang et al., 2022
- Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway, Qing Chang et al., 2020
- Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP, Qing Chang et al., 2019
- SNCA, a novel diagnostic marker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis, Qing Chang et al., 2018
- Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma, Qing Chang et al., 2016
